相关实验视频
Updated: Mar 8, 2026

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.5K
在阿尔茨海默氏病中,粉样蛋白β诱导的炎症可能是阿尔茨海默氏病的原因
Shihui Ding1, Soo-Ho Choi1, Yury I Miller1
1Department of Medicine, University of California, San Diego, CA 92093, USA.
International journal of molecular sciences
|May 28, 2025
概括
阿尔茨海默病涉及粉样β (Aβ) 斑块和神经炎症. 这篇评论强调了微质中的"炎症",表明阿波利波蛋白A-I结合蛋白 (AIBP) 是一种新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 粉样β (Aβ) 斑块的形成是阿尔茨海默病 (AD) 发病的核心原因.
- 在AD中,Aβ在神经炎症和神经退行方面发挥着关键作用.
- 脂质涉到Aβ生产和炎症信号传递.
研究的目的:
- 审查脂质在Aβ生产和微质炎症信号传递中的作用.
- 引入和定义激活微质中"炎症"的概念.
- 讨论新兴的治疗策略,针对AD的炎症.
主要方法:
- 对Aβ,脂质漂泊和神经炎症的现有文献的综述.
- 强调脂质在APP裂变和炎症受体信号传递中的作用.
- 在炎症反应中讨论特定受体 (TLR2,TLR4,CD36,RAGE,TREM2).
主要成果:
- Aβ驱动微质中扩大,富含胆固醇的脂质 ("炎症") 的形成.
- 炎症飞船促进炎症受体的蛋白质-蛋白质和脂质-蛋白质相互作用.
- 这些受体的激活导致细胞因子和反应性氧物种的产生,加剧神经炎症和神经元损伤.
结论:
- 针对炎症向提供了一种新的治疗方法,用于AD.
- 脂蛋白A-I结合蛋白 (AIBP) 是选择性炎症破坏的潜在代理物.
- 破坏炎症可以减轻微质驱动的炎症,并保留生理性脂质功能.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.氨基βββββββββββββββββββββββββ在阿波利波蛋白A-I结合蛋白蛋白中.炎热的飞机可能会发炎.这是一种炎症炎症炎症炎症.脂质漂浮艇是什么意思 脂质漂浮艇是什么意思微质细胞中的微质细胞有活性氧物种的反应性氧物种.更多相关视频
相关概念视频
Amyloid Fibrils
12.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.4K
Amyloid Fibrils
6.8K
6.8K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K

